A cell-based screening identifies compounds from the stem of Momordica charantia that overcome insulin resistance and activate AMP-activated protein kinase

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 16, 2008, Pages 6835-6843

  Cheng, Hsueh Ling ^a   Huang, Hsin Kai ^a   Chang, Chi I ^a   Tsai, Chung Pao ^a   Chou, Chang Hung ^b  

^a NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

AMP activated protein kinase; FL83B cells; Insulin resistance; Momordica charantia; Screening; Triterpenoids

Indexed keywords

AMP ACTIVATED PROTEIN KINASES; AMP-ACTIVATED PROTEIN KINASES; ANTIDIABETIC AGENT; GLUCOSE; MULTIENZYME COMPLEX; PLANT EXTRACT; PROTEIN SERINE THREONINE KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CELL LINE; CHEMISTRY; DRUG EFFECT; ENZYME ACTIVATION; INSULIN RESISTANCE; LIVER; METABOLISM; MOMORDICA CHARANTIA; MOUSE; PLANT STEM;

ANIMALS; CELL LINE; ENZYME ACTIVATION; GLUCOSE; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; LIVER; MICE; MOMORDICA CHARANTIA; MULTIENZYME COMPLEXES; PLANT EXTRACTS; PLANT STEMS; PROTEIN-SERINE-THREONINE KINASES; TUMOR NECROSIS FACTOR-ALPHA;

MOMORDICA CHARANTIA;

EID: 51649085397     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf800801k     Document Type: Article

References (30)

1. Kasuga, M. Insulin resistance and pancreatic beta cell failure. J. Clin. Invest. 2006, 116, 1756-60.
2. Fujimoto, W. Y. The importance of insulin resistance in the pathogenesis of type 2 diabetes mellitus. Am. J. Med 2000, 108, 9S-14S.
3. Lebovitz, H. E.; Banerji, M. A. Treatment of insulin resistance in diabetes mellitus. Eur. J. Pharmacol. 2004, 490, 135-46.
4. Eckel, R. H.; Grundy, S. M.; Zimmet, P. Z. The metabolic syndrome. Lancet 2005, 365, 1415-28.
5. Kahn, B. B.; Flier, J. S. Obesity and insulin resistance. J. Clin. Invest. 2000, 106, 473-81.
6. Grover, J. K.; Yadav, S. P. Pharmacological actions and potential uses of Momordica charantia: a review. J. Ethnopharmacol. 2004, 93, 123-32.
7. Reyes, B. A.; Bautista, N. D.; Tanquilut, N. C.; Anunciado, R. V.; Leung, A. B.; Sanchez, G. C.; Magtoto, R. L.; Castronuevo, P.; Tsukamura, H.; Maeda, K. I. Anti-diabetic potentials of Momordica charantia and Andrographis paniculata and their effects on estrous cyclicity of alloxan-induced diabetic rats. J. Ethnopharmacol. 2006, 105, 196-200.
8. Donya, A.; Hettiarachchy, N.; Liyanage, R.; Lay, J., Jr.; Chen, P.; Jalaluddin, M. Effects of processing methods on the proximate composition and momordicosides K and L content of bitter melon vegetable. J. Agric. Food Chem. 2007, 55, 5827-33.
9. Khanna, P.; Jain, S. C.; Panagariya, A.; Dixit, V. P. Hypoglycemic activity of polypeptide-p from a plant source. J. Nat. Prod. 1981, 44, 648-55.
10. Matsuda, H.; Li, Y.; Murakami, T.; Matsumura, N.; Yamahara, J. III Structure-related inhibitory activity and action mode of oleanolic acid glycosides on hypoglycemic activity. Chem. Pharm. Bull. (Tokyo) 1998, 46, 1399-403.
11. Harinantenaina, L.; Tanaka, M.; Takaoka, S.; Oda, M.; Mogami, O.; Uchida, M.; Asakawa, Y. Momordica charantia constituents and antidiabetic screening of the isolated major compounds. Chem. Pharm. Bull. (Tokyo) 2006, 54, 1017-21.
12. Chen, D.; Elmendorf, J. S.; Olson, A. L.; Li, X.; Earp, H. S.; Pessin, J. E. Osmotic shock stimulates GLUT4 translocation in 3T3L1 adipocytes by a novel tyrosine kinase pathway. J. Biol. Chem. 1997, 272, 27401-10.
13. del Aguila, L. F.; Claffey, K. P.; Kirwan, J. P. TNF-alpha impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells. Am. J. Physiol. 1999, 276, E849-55.
14. Yu, Z. W.; Buren, J.; Enerback, S.; Nilsson, E.; Samuelsson, L.; Eriksson, J. W. Insulin can enhance GLUT4 gene expression in 3T3-F442A cells and this effect is mimicked by vanadate but counteracted by cAMP and high glucose-potential implications for insulin resistance. Biochim. Biophys. Acta 2001, 1535, 174-85.
15. Yoshioka, K.; Takahashi, H.; Homma, T.; Saito, M.; Oh, K. B.; Nemoto, Y.; Matsuoka, H. A novel fluorescent derivative of glucose applicable to the assessment of glucose uptake activity of Escherichia coli. Biochim. Biophys. Acta 1996, 1289, 5-9.
16. Chang, C. I.; Chen, C. R.; Liao, Y. W.; Cheng, H. L.; Chen, Y. C.; Chou, C. H. Cucurbitane-type triterpenoids from Momordica charantia. J. Nat. Prod. 2006, 69, 1168-71.
17. Breslow, J. L.; Sloan, H. R.; Ferrans, V. J.; Anderson, J. L.; Levy, R. I. Characterization of the mouse liver cell line FL83B. Exp. Cell Res. 1973, 78, 441-53.
18. Cheng, H. L.; Chang, S. M.; Cheng, Y. W.; Liu, H. J.; Chen, Y. C. Characterization of the activities of p21Cip1/Waf1 promoter-driven reporter systems during camptothecin-induced senescence-like state of BHK-21 cells. Mol. Cell. Biochem. 2006, 291, 29-38.
19. Hotamisligil, G. S.; Shargill, N. S.; Spiegelman, B. M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259, 87-91.
20. Iwata, M.; Haruta, T.; Usui, I.; Takata, Y.; Takano, A.; Uno, T.; Kawahara, J.; Ueno, E.; Sasaoka, T.; Ishibashi, O.; Kobayashi, M. Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferators- activated receptor-gamma. Diabetes 2001, 50, 1083-92.
21. Rangwala, S. M.; Lazar, M. A. Peroxisome proliferator-activated receptor gamma in diabetes and metabolism. Trends Pharmacol. Sci. 2004, 25, 331-6.
22. Fatope, M. O.; Takeda, Y.; Yamashita, H.; Okabe, H.; Yamauchi, T. New cucurbitane triterpenoids from Momordica charantia. J. Nat. Prod. 1990, 53, 1491-1497.
23. McCarty, M. F. Does bitter melon contain an activator of AMP-activated kinase. Med. Hypotheses 2004, 63, 340-3.
24. Jakobsen, S. N.; Hardie, D. G.; Morrice, N.; Tornqvist, H. E. 5′-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J. Biol. Chem. 2001, 276, 46912-6.
25. Hawley, S. A.; Davison, M.; Woods, A.; Davies, S. P.; Beri, R. K.; Carling, D.; Hardie, D. G. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 1996, 271, 27879-87.
26. Sarkar, S.; Pranava, M.; Marita, R. Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes. Pharmacol. Res. 1996, 33, 1-4.
27. Miura, T.; Itoh, C.; Iwamoto, N.; Kato, M.; Kawai, M.; Park, S. R.; Suzuki, I. Hypoglycemic activity of the fruit of the Momordica charantia in type 2 diabetic mice. J. Nutr. Sci. Vitaminol. (Tokyo) 2001, 47, 340-4.
28. Hardie, D. G. The AMP-activated protein kinase pathway-new players upstream and downstream. J. Cell Sci. 2004, 117, 5479-87.
29. Long, Y. C.; Zierath, J. R. AMP-activated protein kinase signaling in metabolic regulation. J. Clin. Invest. 2006, 116, 1776-83.
30. Du, M.; Shen, Q. W.; Zhu, M. J. Role of beta-adrenoceptor signaling and AMP-activated protein kinase in glycolysis of postmortem skeletal muscle. J. Agric. Food Chem. 2005, 53, 3235-9.